BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18353236)

  • 1. [Pathogenesis and progress in treatment of neonatal total parenteral nutrition-associated cholestasis].
    Zhu MZ; Shan RB
    Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):35-7. PubMed ID: 18353236
    [No Abstract]   [Full Text] [Related]  

  • 2. Total parenteral nutrition-related liver disease.
    Sokol RJ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(6):418-28. PubMed ID: 9473812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis.
    Moss RL; Amii LA
    Semin Pediatr Surg; 1999 Aug; 8(3):140-7. PubMed ID: 10461327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral nutrition-associated cholestasis.
    Teitelbaum DH
    Curr Opin Pediatr; 1997 Jun; 9(3):270-5. PubMed ID: 9229168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatobiliary consequences of parenteral alimentation.
    Balistreri WF; Bove KE
    Prog Liver Dis; 1990; 9():567-601. PubMed ID: 2156315
    [No Abstract]   [Full Text] [Related]  

  • 6. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).
    Ekema G; Falchetti D; Boroni G; Tanca AR; Altana C; Righetti L; Ridella M; Gambarotti M; Berchich L
    J Pediatr Surg; 2008 Jun; 43(6):1191-5. PubMed ID: 18558205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parenteral nutrition related hepato-biliary disease in adults.
    Raman M; Allard JP
    Appl Physiol Nutr Metab; 2007 Aug; 32(4):646-54. PubMed ID: 17622278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease?
    Beau P; Labat-Labourdette J; Ingrand P; Beauchant M
    J Hepatol; 1994 Feb; 20(2):240-4. PubMed ID: 8006405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic and biliary complications during parenteral nutrition].
    Bengoa J
    Rev Med Suisse Romande; 1984 Mar; 104(3):219-23. PubMed ID: 6426014
    [No Abstract]   [Full Text] [Related]  

  • 10. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
    Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
    Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral nutrition and hepatobiliary dysfunction.
    Farrell MK; Balistreri WF
    Clin Perinatol; 1986 Mar; 13(1):197-212. PubMed ID: 3082561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
    Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
    Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver and biliary tract changes and injury associated with total parenteral nutrition: pathogenesis and prevention.
    Briones ER; Iber FL
    J Am Coll Nutr; 1995 Jun; 14(3):219-28. PubMed ID: 8586769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of liver biopsy in the evaluation of pediatric total parenteral nutrition cholestasis.
    Buonpane CL; Ares GJ; Englert EG; Helenowski I; Cohran VC; Hunter CJ
    Am J Surg; 2018 Oct; 216(4):672-677. PubMed ID: 30041734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of cholestasis.
    Alvaro D
    Methods Find Exp Clin Pharmacol; 1996; 18 Suppl B():47-51. PubMed ID: 8899693
    [No Abstract]   [Full Text] [Related]  

  • 16. S-adenosylmethionine prevents total parenteral nutrition-induced cholestasis in the rat.
    Belli DC; Fournier LA; Lepage G; Yousef I; Roy CC
    J Hepatol; 1994 Jul; 21(1):18-23. PubMed ID: 7963417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of ursodeoxycholic acid (UDCA) in the therapy of liver and biliary duct diseases in children.
    Lebensztejn DM
    Med Sci Monit; 2000; 6(3):632-6. PubMed ID: 11208384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic complications of total parenteral nutrition.
    Baker AL; Rosenberg IH
    Am J Med; 1987 Mar; 82(3):489-97. PubMed ID: 3103440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-adenosylmethionine in treatment of cholestasis after total parenteral nutrition: laboratory investigation and clinical application.
    Li N; Zhang HH; Wang SH; Zhu WM; Ren JA; Li JS
    Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):96-100. PubMed ID: 14607634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition.
    Arslanoglu S; Moro GE; Tauschel HD; Boehm G
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):228-31. PubMed ID: 18223390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.